Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy
NCT05442021 · View on ClinicalTrials.gov ↗
Study Summary
This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit, in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.
Conditions Studied
Interventions
- DEVICE TENS
- DEVICE Neubie Direct Current Electrical Stimulation Device
Study Locations (11)
Florida
- APEX Physical Therapy — Cape Coral
- Catalyst Physical Therapy — Clearwater
- APEX Physical Therapy — Fort Myers
New York
- Hands-On Physical Therapy — Astoria
- Hands-On Physical Therapy of Queens Village — Queens Village
- Panetta Physical Therapy & Diagnostics — Ronkonkoma
West Virginia
- Active Fitness Physical Therapy — Oak Hill
- Active Fitness Physical Therapy — Victor
Kentucky
- Diagnostic Solutions — Springfield
Oklahoma
- Courcier Physical Therapy — Edmond
Texas
- Spine & Rehab Specialists — El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2023-05-20 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05442021
The ClinicalTrials.gov registry entry for NCT05442021 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NeuFit - Neurological Fitness and Education, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Neuropathy appearing as the primary indexed condition, and to 2 interventions — of which TENS is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05442021 reports 11 study locations spanning 6 distinct geographic areas — top geographies include Florida, New York, West Virginia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05442021 about?
NCT05442021 is a clinical study titled "Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy". This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much...
What is the current status of trial NCT05442021?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2022-08-01. Estimated completion is 2023-05-20.
What conditions does trial NCT05442021 study?
This clinical trial studies the following conditions: Neuropathy. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05442021?
The interventions under investigation include: TENS (DEVICE), Neubie Direct Current Electrical Stimulation Device (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05442021?
This trial is sponsored by NeuFit - Neurological Fitness and Education, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05442021 being conducted?
This trial has 11 study locations across Florida, Kentucky, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.